NovoCure (NVCR) reported 154.99millioninrevenueforthequarterendedMarch2025,representingayear−over−yearincreaseof11.90.31 for the same period compares to -0.36ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof147.57 million, representing a surprise of +5.03%. The company delivered an EPS surprise of +34.04%, with the consensus EPS estimate being -$0.47.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- a ...